Literature DB >> 2537854

Papillomavirus and c-myc antigen expression in normal and neoplastic cervical epithelium.

R G Hughes1, W A Neill, M Norval.   

Abstract

Cervical punch biopsy specimens or brushings were collected from 33 patients with cervical human papilloma virus (HPV) infection, cervical intraepithelial neoplasia (CIN), or invasive cervical carcinoma, and from eight control patients with recent normal cervical cytology. Prostatic chippings obtained from six men with benign prostatic hypertrophy were used as further controls. Biopsy specimens and brushings were assayed by flow cytometry for c-myc oncogene antigen and papillomavirus antigen expression and rate of cell division (by measuring DNA content). Results obtained from analysis of specimens and brushings were similar in terms of c-myc antigen and total DNA content, but when the percentages of nuclei from biopsy and brush specimens staining positively with antibody to papilloma viral antigens were compared, brush specimens gave consistently higher percentages than biopsy specimens. More specimens from normal epithelium were c-myc antigen positive (five of eight, (63%) than specimens from CIN II or III (two of 10, 20%), or invasive carcinoma (0%). No association was found between c-myc antigen expression and cell division. HPV antigen positive specimens were found to contain more dividing cells than negative specimens.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2537854      PMCID: PMC1141789          DOI: 10.1136/jcp.42.1.46

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  32 in total

1.  Non-invasive detection of cervical papillomavirus DNA.

Authors:  D J McCance; M J Campion; A Singer
Journal:  Lancet       Date:  1986-03-08       Impact factor: 79.321

2.  Multidimensional slit-scan prescreening system: preliminary results of a single blind clinical study.

Authors:  L L Wheeless; S F Patten; T K Berkan; C L Brooks; K M Gorman; S R Lesh; P A Lopez; J C Wood
Journal:  Cytometry       Date:  1984-01

3.  Flow cytometric DNA analysis as a diagnostic aid for cervical condyloma and cancer.

Authors:  K C Tsou; D H Hong; M Varello; R Giuntoli; J E Wheeler; B F Atkinson; C Mangan; J Mikuta
Journal:  Cancer       Date:  1984-11-01       Impact factor: 6.860

4.  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

Authors:  D W Hedley; M L Friedlander; I W Taylor; C A Rugg; E A Musgrove
Journal:  J Histochem Cytochem       Date:  1983-11       Impact factor: 2.479

5.  High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix.

Authors:  R Ocadiz; R Sauceda; M Cruz; A M Graef; P Gariglio
Journal:  Cancer Res       Date:  1987-08-01       Impact factor: 12.701

6.  [Presence of papillomavirus genomes and amplification of the c-myc and C-Ha-ras oncogenes in invasive cancers of the uterine cervix].

Authors:  G Riou; M Barrois; I Tordjman; V Dutronquay; G Orth
Journal:  C R Acad Sci III       Date:  1984

7.  Screening for wart virus infection in normal and abnormal cervices by DNA hybridisation of cervical scrapes.

Authors:  C Wickenden; A Steele; A D Malcolm; D V Coleman
Journal:  Lancet       Date:  1985-01-12       Impact factor: 79.321

8.  Prevalence of human papillomavirus type 16 DNA sequences in cervical intraepithelial neoplasia and invasive carcinoma of the cervix.

Authors:  D J McCance; M J Campion; P K Clarkson; P M Chesters; D Jenkins; A Singer
Journal:  Br J Obstet Gynaecol       Date:  1985-11

9.  Close link between reduction of c-myc expression by interferon and, G0/G1 arrest.

Authors:  M Einat; D Resnitzky; A Kimchi
Journal:  Nature       Date:  1985 Feb 14-20       Impact factor: 49.962

10.  Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle.

Authors:  P H Rabbitts; J V Watson; A Lamond; A Forster; M A Stinson; G Evan; W Fischer; E Atherton; R Sheppard; T H Rabbitts
Journal:  EMBO J       Date:  1985-08       Impact factor: 11.598

View more
  4 in total

1.  Alterations in exon 1 of c-myc and expression of p62c-myc in cervical squamous cell carcinoma.

Authors:  J J O'Leary; R J Landers; M Crowley; I Healy; W F Kealy; J Hogan; C T Doyle
Journal:  J Clin Pathol       Date:  1997-11       Impact factor: 3.411

2.  Endocervical carcinoma and precursor lesions: c-myc expression and the demonstration of field changes.

Authors:  S V Polacarz; J Darne; E G Sheridan; R Ginsberg; F Sharp
Journal:  J Clin Pathol       Date:  1991-11       Impact factor: 3.411

3.  C-myc oncogene expression in anal squamous neoplasia.

Authors:  O A Ogunbiyi; J H Scholefield; K Rogers; F Sharp; J H Smith; S V Polacarz
Journal:  J Clin Pathol       Date:  1993-01       Impact factor: 3.411

4.  Nuclear proto-oncogene products transactivate the human papillomavirus type 16 promoter.

Authors:  W Nürnberg; M Artuc; G Vorbrueggen; F Kalkbrenner; K Moelling; B M Czarnetzki; D Schadendorf
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.